Enhancing the in vitro and in vivo detection of aneuploidy by fluorescence in situ hybridization with the use of bromodeoxyuridine as a proliferation marker

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 521, Issue 1-2, 2002, Pages 81-89

  Balakrishnan, S ^a   Payawal, J ^a   Schuler, M J ^a   Hasegawa, L ^a   Eastmond, D A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aneuploidy; BrdU labeling; Hyperdiploidy; In vivo; Noscapine hydrochloride; Rat hepatocytes; Rat lymphocytes; Vinblastine sulfate; Vincristine sulfate

Indexed keywords

ANEUGEN; BROXURIDINE; CELL MARKER; NOSCAPINE; VINBLASTINE SULFATE; VINCRISTINE;

ANEUPLOIDY; ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CULTURE; CELL DIVISION; CELL PROLIFERATION; CHROMOSOME 4; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME NUMBER; CONTROLLED STUDY; CULTURE MEDIUM; DIPLOIDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENDER; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LYMPHOCYTE; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANEUPLOIDY; ANIMALS; BIOLOGICAL MARKERS; BROMODEOXYURIDINE; CELL DIVISION; CELLS, CULTURED; HEPATOCYTES; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MALE; NOSCAPINE; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; VINBLASTINE; VINCRISTINE;

EID: 0037180387     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(02)00220-6     Document Type: Article

References (37)

1. Hassold T., Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat. Rev. Genet. 2:2001;280-291.
2. F. Hecht, B.K. Hecht, Aneuploidy in humans: dimensions, demography and dangers of abnormal numbers of chromosomes, in: B.K. Vig, A.A. Sandberg (Eds.), Aneuploidy, Part. A: Incidence and Etiology, New York, Liss, 1987, 2v pp.
3. Griffin D.K. The incidence, origin, and etiology of aneuploidy. Int. Rev. Cytol. 167:1996;263-296.
4. Cavenee W.K., Dryja T.P., Phillips R.A., Benedict W.F., Godbout R., Gallie B.L., Murphree A.L., Strong L.C., White R.L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 305:1983;779-784.
5. Duesberg P., Rausch C., Rasnick D., Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc. Natl. Acad. Sci. U.S.A. 95:1998;13692-13697.
6. Li R., Sonik A., Stindl R., Rasnick D., Duesberg P. Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3236-3241.
7. Oshimura M., Barrett J.C. Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer. Environ. Mutagen. 8:1986;129-159.
8. A.A. Sandberg, The Chromosomes in Human Cancer and Leukemia, Elsevier, New York, 1980.
9. J.C. Barrett, M. Oshimura, N. Tanaka, T. Tsutsui, Genetic and epigenetic mechanisms of presumed nongenotoxic carcinogens, in: B.E. Butterworth, T.J. Slaga (Eds.), Banbury Report 25: Nongenotoxic Mechanisms in Carcinogenesis, Cold-Spring Harbor Laboratory, Cold-Spring Harbor, NY, 1987, pp. 311-324.
10. Holliday R. Chromosome error propagation and cancer. Trends Genet. 5:1989;42-45.
11. Angelosanto F.A. Tissues other than bone marrow that can be used for cytogenetic analyses. Environ. Mol. Mutagen. 25:1995;338-343.
12. IARC, Overall evaluations of carcinogenicity: an updating of IARC monographs, Monographs on the Evaluation of Carcinogenic Risks to Humans (ed.). International Agency for Research on Cancer, Lyon: IARC Scientific Publications; 440, vols. 1-42, Supplement 7, 1987.
13. IARC, 4,4′-Methylene bis(2-chloroaniline), International Agency for Research on Cancer, Monographs on the evaluation of carcinogenic risks to humans, vol. 57, 1993, pp. 271-305.
14. IARC, Ortho-Toluidine, International Agency for Research on Cancer, Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 77, 2000, pp. 267-323.
15. IARC, Diazepam, International Agency for Research on Cancer, Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 66, 1996, pp. 37-97.
16. IARC, Griseofulvin, International Agency for Research on Cancer, Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 79, 2001, pp. 291-319.
17. Liehr J.G. Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev. 21:2000;40-54.
18. Sargent L.M., Dragan Y.P., Sattler C., Bahnub N., Sattler G., Martin P., Cisneros A., Mann J., Thorgeirsson S., Jordan V.C., Pitot H.C. Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats. Carcinogenesis. 17:1996;1051-1056.
19. Shelby M.D., Tice R.R., Witt K.L. 17-beta-Estradiol fails to induce micronuclei in the bone marrow cells of rodents. Mutat. Res. 395:1997;89-90.
20. Styles J.A., Davies A., Davies R., White I.N., Smith L.L. Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human P450 cDNAs (MCL-5 cells). Carcinogenesis. 18:1997;303-313.
21. Williams G.M., Ross P.M., Jeffrey A.M., Karlsson S. Genotoxicity studies with the antiestrogen toremifene. Drug Chem. Toxicol. 21:1998;449-476.
22. Hoebee B., de Stoppelaar J.M. The isolation of rat chromosome probes and their application in cytogenetic tests. Mutat. Res. 372:1996;205-210.
23. B. Goz, W.H. Prusoff, Halogenated pyrimidine deoxyribonucleosides, in: A.C. Sartorelli, D.G. Johns (Eds.), Antineoplastic and Immunosuppressive Agents, Springer-Verlag, New York, 1974/1975, pp. 273-347.
24. Balakrishnan S., Uppala P.T., Rupa D.S., Hasegawa L., Eastmond D.A. Detection of micronuclei, cell proliferation and hyperdiploidy in bladder epithelial cells of rats treated with o-phenylphenol. Mutagenesis. 17:2002;89-93.
25. Trask B., Pinkel D. Fluorescence in situ hybridization with DNA probes. Meth. Cell Biol. 33:1990;383-400.
26. Margolin B.H., Resnick M.A., Rimpo J.Y., Archer P., Galloway S.M., Bloom A.D., Zeiger E. Statistical analyses for in vitro cytogenetic assays using Chinese hamster ovary cells. Environ. Mutagen. 8:1986;183-204.
27. Gatehouse D.G., Stemp G., Pascoe S., Wilcox P., Hawker J., Tweats D.J. Investigations into the induction of aneuploidy and polyploidy in mammalian cells by the anti-tissue agent noscapine hydrochloride. Mutagenesis. 6:1991;279-283.
28. Mitchell I.D., Carlton J.B., Chan M.Y., Robinson A., Sunderland J. Noscapine-induced polyploidy in vitro. Mutagenesis. 6:1991;479-486.
29. Schuler M., Muehlbauer P., Guzzie P., Eastmond D.A. Noscapine hydrochloride disrupts the mitotic spindle in mammalian cells and induces aneuploidy as well as polyploidy in cultured human lymphocytes. Mutagenesis. 14:1999;51-56.
30. Channarayappa J.N., Ong T. Clastogenic and aneuploidogenic effects of cigarette smoke condensate mitomycin, C and vincristine sulfate. Mutagenesis. 7:1992;457-460.
31. Degraeve N. Genetic and related effects of Vinca rosea alkaloids. Mutat. Res. 55:1978;31-42.
32. Eastmond D.A., Tucker J.D. Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ. Mol. Mutagen. 13:1989;34-43.
33. Liang J.C., Satya-Prakash K.L. Induction of aneuploidy by mitotic arrestants in mouse bone marrow. Mutat. Res. 155:1985;61-70.
34. Eastmond D.A., Pinkel D. Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutat. Res. 234:1990;303-318.
35. Eastmond D.A., Schuler M., Rupa D.S. Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutat. Res. 348:1995;153-162.
36. Zwanenburg T.S., Mullenders L.H., Natarajan A.T., van Zeeland A.A. DNA lesions, chromosomal aberrations and G2 delay in CHO cells cultured in medium containing bromo- or chloro-deoxyuridine. Mutat. Res. 127:1984;155-168.
37. David J., Gordon J.S., Rutter W.J. Increased thermal stability of chromatin containing 5-bromodeoxyuridine-substituted DNA. Proc. Natl. Acad. Sci. U.S.A. 71:1974;2808-2812.